Teriflunomide treatment outcomes in multiple sclerosis: A Portuguese real-life experience

Teriflunomide is an oral disease-modifying therapy for relapsing–remitting multiple sclerosis patients. A decline in physical and cognitive functions, which negatively impacts their quality of life (QoL), is observed in relapsing–remitting multiple sclerosis patients. The aim of this study was to ch...

Descripción completa

Detalles Bibliográficos
Autores principales: Nunes, Carla Cecília, Abreu, Pedro, Correia, Filipe, Mendes, Irene, da Silva, Ana Martins
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363901/
https://www.ncbi.nlm.nih.gov/pubmed/37492519
http://dx.doi.org/10.1177/23982128231185290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363901/
https://www.ncbi.nlm.nih.gov/pubmed/37492519
http://dx.doi.org/10.1177/23982128231185290

Ejemplares similares